Moleculin Biotech Stock Forecast - Relative Strength Index
| MBRX Stock | USD 4.61 0.09 1.99% |
Moleculin Stock outlook is based on your current time horizon.
At this time, the RSI of Moleculin Biotech's share price is approaching 39. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Moleculin Biotech, making its price go up or down. Momentum 39
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (5.28) | EPS Estimate Next Year (4.85) | Wall Street Target Price 6.6667 |
Using Moleculin Biotech hype-based prediction, you can estimate the value of Moleculin Biotech from the perspective of Moleculin Biotech response to recently generated media hype and the effects of current headlines on its competitors.
Moleculin Relative Strength Index
Moleculin Biotech Hype to Price Pattern
Investor biases related to Moleculin Biotech's public news can be used to forecast risks associated with an investment in Moleculin. The trend in average sentiment can be used to explain how an investor holding Moleculin can time the market purely based on public headlines and social activities around Moleculin Biotech. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Moleculin Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Moleculin Biotech.
Moleculin Biotech after-hype prediction price | USD 4.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Moleculin | Build AI portfolio with Moleculin Stock |
Moleculin Biotech Additional Predictive Modules
Most predictive techniques to examine Moleculin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Moleculin using various technical indicators. When you analyze Moleculin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 39.88 | 39.88 |
| Check Moleculin Biotech Volatility | Backtest Moleculin Biotech | Information Ratio |
Moleculin Biotech Trading Date Momentum
| On January 28 2026 Moleculin Biotech was traded for 4.61 at the closing time. The top price for the day was 4.61 and the lowest listed price was 4.52 . There was no trading activity during the period 0.0. Lack of trading volume on January 28, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.95% . |
| Compare Moleculin Biotech to competition |
Other Forecasting Options for Moleculin Biotech
For every potential investor in Moleculin, whether a beginner or expert, Moleculin Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Moleculin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Moleculin. Basic forecasting techniques help filter out the noise by identifying Moleculin Biotech's price trends.Moleculin Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Moleculin Biotech stock to make a market-neutral strategy. Peer analysis of Moleculin Biotech could also be used in its relative valuation, which is a method of valuing Moleculin Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Moleculin Biotech Market Strength Events
Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech entry and exit signals to maximize returns.
Moleculin Biotech Risk Indicators
The analysis of Moleculin Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Moleculin Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting moleculin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.73 | |||
| Standard Deviation | 6.91 | |||
| Variance | 47.71 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Moleculin Biotech
The number of cover stories for Moleculin Biotech depends on current market conditions and Moleculin Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Moleculin Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Moleculin Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Moleculin Biotech Short Properties
Moleculin Biotech's future price predictability will typically decrease when Moleculin Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Moleculin Biotech often depends not only on the future outlook of the potential Moleculin Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Moleculin Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 137.7 K | |
| Cash And Short Term Investments | 4.3 M |
Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.